Filter your results
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Concerns about the widespread use of rodent models for human risk assessments of endocrine disruptors.Reproduction, 2014, 147 (4), pp.R119-29. ⟨10.1530/REP-13-0497⟩
Journal articles
pasteur-01135729v1
|
||
Avis de l'Anses relatif à l’évaluation du triphénylphosphate (TPP) (EC No 204-112-2 ; CAS No 115-86-6) dans le cadre de l’évaluation des substances sous REACHSaisine n°2022-REACh-0027, Anses. 2023, 12 p
Reports
anses-04166740v1
|